International Journal of Medical and Pharmaceutical Research
2026, Volume-7, Issue 4 : 1305-1315
Research Article
Anobservational Study on Impact of Maternal Body Mass Index on Maternal and Neonatal Outcome
 ,
 ,
Received
June 20, 2026
Accepted
July 1, 2026
Published
July 17, 2026
Abstract

Background: Obesity is a growing health problem worldwide. According to World Health Organization (WHO) obesity is defined as abnormal or excessive fat accumulation that may impair health and body mass index (BMI) of 30kg/m² ormore as obese among adults. The prevalence of obesity is increasing in pregnancy. Obesity in pregnancy is responsible for several complications affecting the mother and fetus such as hypertensive disorders of pregnancy (HDP), gestational diabetes mellitus (GDM), dysfunctional labour, preterm labour, caesarean sections, postpartum infections and deep vein thrombosis. And the neonatal complications were congenital malformations, large for gestational age, macrosomic, prematurity, had high incidences of birth injuries, shoulder dystocia and late fetal deaths.

Objectives: To evaluate the impact of maternal BMI on maternal outcomes in terms of Percentage of weight gain in pregnancy Hypergycemia in pregnancy Hypertensive disorders of pregnancy Mode of delivery

To evaluate the impact of maternal BMI on fetal outcomes interms of Birth weight APGAR score NICU admission

Methodology: The study was conducted among 100 patients visiting antenatal clinic at Dr. B R Ambedkar medical college and hospital under strict inclusion and exclusion criteria

Results: Majority of the women were in the age category 21-25 years, 53 (53%), followedby26-30 years in 30 (30%). Primigravida 39(39%), followed by second

gravida36 (36%), third gravida in 15 (15%) and multigravida (>3)in 10 (10%)of the patients respectively. The mean gestational age among the pregnant women was 37.5 weeks. Normal vaginal delivery was the most common mode of delivery, observed in 66 cases (66%). The mean maternal height was 1.60±0.08 meters, the mean maternal weight was 61.456 ± 8.66 kg, and the mean maternal BMI was 23.82 ± 2.62 kg/m².

The majority of participants, 68 cases (68%), were classified under BMI Category II (23–24.9kg/m²), category I (18–22.9kg/m²) included 20 cases (20%),12 cases (12%) fell under Category III (≥ 25 kg/m²), corresponding to the obese group. 49 women (49%), had a maternal weight gain between7–11.5kg, 30 women (30%) gained

11.6–15 kg, of 17 women (17%) had weight gain of more than 15 kg, 4 women (4%) gained less than 7 kg. 19(19%) of the women had gestational diabetes.

28(28%) of the women had hypertensive disorder. The mean birth weight among the neonates was 2.78±0.53 grams. The mean 1 minute Apgar score was 6±1.96 among the neonates. The mean 5 minute Apgar score was 6.94±1.59 among the neonates. 34 (34%) of the neonates required NICU admission. The most common neonatal complication observed was birth asphyxia, affecting 25 neonates (25%).

Conclusion: This study emphasizes that maternal BMI, weight gain impact pregnancy and neonatal outcomes. . Strengthening antenatal education, nutritional support, and delivery preparedness is essential. Multidisciplinary approaches integrating obstetrics, neonatology, dietetics, and endocrinology can pave the way toward safer pregnancies and healthier neonates.

Keywords
INTRODUCTION

Maternal nutritional status is one of the most important determinants of pregnancy outcome, with maternal body mass index (BMI) serving as a simple and reliable indicator of nutritional health. The increasing prevalence of overweight and obesity among women of reproductive age has become a major public health concern worldwide. According to the World Health Organization (WHO), obesity is defined as abnormal or excessive fat accumulation that may impair health, with a BMI of ≥30 kg/m² in adults. However, for Asian populations, lower BMI cut-offs are recommended because of the increased risk of metabolic disorders at relatively lower BMI values.

 

Pregnancy is associated with significant physiological, metabolic, and hormonal adaptations that support fetal growth and development. Maternal BMI before and during pregnancy plays a crucial role in influencing these adaptations and has a substantial impact on both maternal and neonatal outcomes. Both underweight and overweight women are at increased risk of adverse obstetric events. Excess maternal weight is associated with insulin resistance, chronic inflammation, endothelial dysfunction, and altered placental function, predisposing pregnant women to complications such as gestational diabetes mellitus (GDM), hypertensive disorders of pregnancy (HDP), preeclampsia, prolonged labour, operative vaginal delivery, caesarean section, postpartum haemorrhage, wound infections, and thromboembolic events.

 

Maternal obesity also has significant implications for fetal and neonatal health. Infants born to overweight or obese mothers have an increased risk of congenital anomalies, fetal macrosomia, large-for-gestational-age status, birth trauma, shoulder dystocia, preterm birth, neonatal hypoglycaemia, respiratory distress syndrome, low Apgar scores, neonatal intensive care unit (NICU) admission, and perinatal mortality. Conversely, inadequate maternal BMI and poor gestational weight gain are associated with fetal growth restriction, low birth weight, preterm birth, and increased neonatal morbidity.

 

India is currently experiencing a nutritional transition characterized by the coexistence of undernutrition and increasing rates of overweight and obesity among women of childbearing age. Changes in dietary habits, urbanization, reduced physical activity, and sedentary lifestyles have contributed to this growing burden. Consequently, understanding the relationship between maternal BMI and pregnancy outcomes has become increasingly important for optimizing antenatal care and reducing maternal and neonatal complications.

 

Body mass index is an inexpensive, non-invasive, and widely accepted screening tool that can be easily incorporated into routine antenatal practice. Early identification of women with abnormal BMI enables healthcare providers to implement appropriate nutritional counselling, weight management strategies, close surveillance for pregnancy-related complications, and individualized obstetric care.

 

Although several studies have demonstrated an association between maternal BMI and adverse pregnancy outcomes, variations exist across different populations due to differences in ethnicity, socioeconomic status, dietary patterns, and healthcare access. Therefore, evaluating these associations in the local population is essential for developing context-specific preventive and management strategies.

 

The present prospective observational study was undertaken to evaluate the impact of maternal body mass index on maternal and neonatal outcomes among pregnant women attending the antenatal clinic at Dr. B. R. Ambedkar Medical College and Hospital. The study aims to assess the association between maternal BMI and pregnancy complications, mode of delivery, gestational weight gain, birth weight, Apgar score, and NICU admission, thereby contributing evidence to improve antenatal risk stratification and maternal–fetal healthcare outcomes.

 

MATERIALSANDMETHODS

Source of study: All pregnant women attending antenatal clinic at the DRBR Ambedkar medical college and hospital during study period.

 

Sample size: 100

 

Study design: Prospective Observational study

 

Study place: Department of OBG, Dr. B R AMBEDKAR MEDICAL COLLEGEANDHOSPITAL.

Study period: May2023 to October 2024

 

Method of collection of Data

Written informed consent will be taken from patient for willingness to participate in study and to follow up till delivery.

Demographic data, clinical data collected

 

All the antenatal mother during the irfirst visit to antenatal clinic, asked appropriate history of present pregnancy, past history, family history, personal history, and general physical examination and BMI calculated.

 

The women is categorized according other BMI CATEGORY 1 – BMI 18.0–22.9 Kg/m²

CATEGORY 2– BMI23.0–24.9Kg/m²

 

CATEGORY3– BMI>25 Kg/m²

 

Women underwent regular ANC investigations including OGCT, Serum TSH. The antenatal women is advised to follow up regularly till delivery.

 

Under maternal outcome, the variables studied included percentage of weight gain in pregnancy, hyperglycemia in pregnancy, hypertensive disorders of pregnancy, mode of delivery.

Under neonatal outcomes the variables studied included birth weight, APGAR, NICU admission.

 

Inclusion criteria:

Age of 18–35 years. Singleton pregnancy Spontaneous conception

 

Exclusion criteria:

Women with multiplepregnancies

 

Women with chronic diseases such as hypertension, diabetes Women with previous cesarean section

Women with uterine and fetal congenital anomalies.

 

STATISTICAL ANALYSIS:

Statistical Methods:

Data entered in to Microsoft Excel data sheet and analyzed using SPSS22 version software.

Categorical data represented in the form of Frequencies and proportions. Chi-square used as test of significance.

Continuous data represented as mean and standard deviation. Student’s t-test the test of significance for quantitative data.

 

p-value<0.05consideredas statistically significant.

 

Sample Size:100

Sample size of 100 selected, based on the below mentioned formula: P = 41.67%, Q = 100 – 41.67 = 58.33%

L=Absoluteprecisionwas10% Sample size (n) = Z² × PQ / L²

=(1.96)²×41.67×58.33/(10)² n = 9337.43 / 100

n =93.37

 

Samplesizen =Round figure100 cases

 

RESULTS

Age

The mean age of the patients was 24.88±3.55 years. Majority of the women were in the age category 21-25 years, 53(53%), followed by 26-30 years in 30(30%) respectively. The results were shown in table 1 and chart 1.

 

Table4: Agewise distribution among the study participants

Agecategory(Years)

Frequency

Percentage(%)

18-20

10

10

21-25

53

53

26-30

30

30

>30

7

7

Total

100

100

 

Fig 1:Age wise distribution among the study participants

 

Gravida

In this study, the majority of women were primigravida 39(39%), followed by second gravida 36 (36%), third gravida in 15 (15%) and multigravida (>3) in 10 (10%) of the patients respectively. The results were shown in table 2 and chart 2.

 

Table5: Distribution of gravida among the study participants

Gravida

Frequency

Percentage(%)

Primigravida

39

39

Secondgravida

36

36

Thirdgravida

15

15

Multigravida(>3)

10

10

 

Fig2:Distribution of gravida among the study participants

 

Gestational Age

The mean gestational age among the pregnant women was 37.55±2.27 weeks. In the present study, most participants (66%) had a gestational age between 38–40 weeks, indicating that the majority delivered at term. A smaller proportion (18%) had gestational age between 34–37 weeks, corresponding to late preterm deliveries, while 9% delivered before 34 weeks, suggesting earlypretermbirths. Only 7% of pregnancies extended beyond40 weeks, reflecting limited occurrence of post-term deliveries. The results were shown in table 3 and chart 3.

 

Table 6: Distribution of gestational age among the study participants

 Gestational age category

(in weeks)

Frequency

Percentage(%)

<34

9

9

34-37

18

18

38-40

66

66

>40

7

7

 

Fig3: Distribution of gestational age among the study participants

 

Mode of delivery

In the present study, normal vaginal delivery was the most common mode of delivery, observed in 66 cases (66%), reflecting a predominance of spontaneous deliveries. Instrumental deliveries were note din 16 cases (16%), indicating assistedvaginal births using forceps or vacuum extraction when required. Caesarean sections accounted for 18 cases (18%), representing deliveries necessitating surgical intervention due to maternal or fetal indications.The results were shown in table 4 and chart 4.

 

Table7: Mode of delivery among the study participants

Modeof Delivery

Frequency

Percentage(%)

NormalVaginal

66

66

CaesareanSection

18

18

Instrumental

16

16

 

Fig4:Mode of delivery among the study participants

 

Anthropometric details

In the present study, the mean maternal height was 1.60 ± 0.08 meters, the mean maternal weight was 61.456 ± 8.66 kg, and the mean maternal BMI was 23.82 ± 2.62 kg/m². The results were shown in table 5.

 

Table 8: Anthropometric details of the study population

Anthropometric Parameters

Mean

SD

Maternal Height (meters)

1.6052

0.08

Maternal Weight (inKgs)

61.456

8.66

Maternal BMI (Kg/m2)

23.829

2.62

 

BMI category

In the presentstudy, the majority of participants, 68cases (68%),wereclassifiedunder BMICategoryII (23–24.9kg/m²),representingtheoverweight BMIrange. CategoryI (18–22.9 kg/m²) included 20 cases (20%), indicating a smaller proportion of normal weight women. Only 12 cases (12%) fell under Category III (≥ 25 kg/m²), corresponding to the obese group.. The results were shown in table 6 and Chart 5.

 

Table 9: BMI category among the study participants

BMICategory

BMIrange(Kg/m2)

Frequency

Percentage

CategoryI

18-22.9

20

20.0

CategoryII

23-24.9

68

68.0

CategoryIII

≥25

12

12.0

 

Fig 5: BMI category among the study participants

 

Percentage weight gain

In the present study, the majority of participants, 49 women (49%), had a maternal weightgainbetween7–11.5 kg,indicatingadequategestationalgain.30women(30%) gained 11.6–15 kg, reflecting optimal or slightly higher weight gain. A smaller group of 17 women (17%) had weight gain of more than 15 kg, suggesting excessive gain, while only 4 women (4%) gained less than 7 kg, representing inadequate weight gain during pregnancy. The results were shown in table 7 and Chart 6.

 

Table10: Percentage weight gain among the study participants

Percentageweightgain(Kgs)

Frequency

Percentage(%)

<7

4

4

7-11.5

49

49

11.6-15

30

30

>15

17

17

 

Fig 6: Percentage weight gain among the study participants

 

Gestational Diabetes

Inthisstudy,19(19%)of the women had gestational diabetes.The results were shown in table 8 and Chart 7.

 

Table11:Incidence of Gestational Diabetes among the study participants

Gestational Diabetes

Frequency

Percentage(%)

Yes

19

19

No

81

81

 

Fig7: Incidence of Gestational Diabetes among the study participants

 

Hypertensive disorder

In this study, 28(28%) of the women had hypertensive disorder. The results were shown in table 9 and Chart 8.

 

Table12: Incidence of hypertensive disorder among the study participants

Hypertensive disorder

Frequency

Percentage(%)

Yes

28

28

No

72

72

 

Fig 8: Incidence of hypertensive disorder among the study participants

 

Neonatal outcome Birth weight

The mean birth weight among the neonates was 2.78±0.53 grams. Majority of the neonates had birth weight > 3 Kgs in 90(90%), followed by 10 (10%) of the neonates had birth weight between 2.5-3Kgs. The results were shown in table 10 and Chart 9.

 

Table13:Birth weight categories among the neonates

Birth weight category(Kgs)

Frequency

Percentage(%)

2.5-3

10

10

>3

90

90

 

Fig 9: Birth weight categories among the neonates

 

APGA Rscoresat 1 minute

The mean 1 minute Apgar score was 6±1.96 among the neonates. Majority of the neonates had APGA Rscores<7,25(25%).The results were shown in Table11and chart 10.

 

Table14: APGA Rscoresat 1 minute among the neonates

APGARscoresat1 minute

Frequency

Percentage(%)

<7

25

25

>7

75

75

 

Fig10: APGA Rscores at 1 minute among the neonates

 

APGAR scores at 5 minute

The mean 5 minute Apgar score was 6.94±1.59 among the neonates. Majority of the neonates had APGAR scores<7,55(55%). The results were shown in Table 12 and chart 11.

 

Table15: APGA Rscores at 5 minute among the neonates

APGA Rscores at 5 minute

Frequency

Percentage(%)

<7

55

55

<7

45

45

 

Fig 11: APGAR scores at 5 minute among the neonates

 

Neonatal Complications

In the present study, the most common neonatal complication observed was birth asphyxia, affecting 25 neonates (25%).Sepsisandhypoglycemiawereeachreportedin 19 cases (19%), highlightingsignificant early neonatal morbidity. Respiratorydistress wasnotedin11 cases (11%),indicating compromised neonatal respiratory adaptation. Importantly, 26 neonates (26%) had no complications,suggestingafavourableoutcome in about one-fourth of the cohort. The results were shown in table 13 and chart 12.

 

Table16: Neonatal complicationsin the present study

NeonatalComplications

Frequency

Percentage(%)

BirthAsphyxia

25

25

Sepsis

19

19

Hypoglycemia

19

19

RespiratoryDistress

11

11

No complications

26

26

 

NICU Admission

In this study, 34(34%) of the neonates required NICU admission. The results were shown in table 14 and chart 13.

 

Table17: NICU Admission among the neonates

NICU Admission

Frequency

Percentage(%)

Yes

34

25

No

66

19

 

Fig13: NICU Admission among the neonates

 

SUMMARY

The study involved 100 pregnant women with a mean maternal age of 24.88 ± 3.55 years, the majority (53%) falling in the 21–25 years category. In terms of obstetric history, 39% were primigravida, followed by 36% second gravida. Most participants (66%)delivered after gestational age(38–40weeks),while 9% had preterm delivery before 34 weeks, and only 7% extended beyond 40 weeks.

 

Normal vaginal delivery was the most common mode of delivery (66%), with 18% undergoing caesarean section and 16% requiring instrumental assistance. The mean maternal height was 1.6052±0.08 meters, weight 61.46±8.66kg, and BMI23.82±2.62 kg/m².  Most women (68%) were classified under BMI Category II (23–24.9 kg/m²), suggesting a predominantly normal to high-normal BMI distribution.

 

Regarding gestational weight gain, 49% of participants gained 7–11.5 kg, indicating adequategain, while 17% had excessive gain(>15kg), and only 4%gained lessthan7 kg. Medical complications included gestational diabetes in 19% and hypertensive disorders in 28% of women.

 

Among neonatal outcomes, the mean birth weight was 2.78 ± 0.53 kg, with 90% of neonates weighing more than 3 kg. The mean Apgar scores were 6 ± 1.96 at 1 minute and 6.94 ± 1.59 at 5 minutes. Notably, 25% had Apgar <7 at 1 minute, and 55% had Apgar <7 at 5 minutes, indicating delayed neonatal adaptation in a subset.

 

Common neonatal complications included birth asphyxia (25%), sepsis (19%), hypoglycemia (19%), and respiratory distress(11%), while 26% of neonates had no complications. NICU admission was required in 34% of cases, indicating a considerable burden of immediate postnatal care requirements.

 

CONCLUSION

In conclusion, this study emphasizes that maternal BMI, weight gain impact pregnancy and neonatal outcomes. . Strengthening antenatal education, nutritional support, and delivery preparedness is essential. Multidisciplinary approaches integrating obstetrics, neonatology, dietetics, and endocrinology can pave the way toward safer pregnancies and healthier neonates.

 

REFERENCES

  1. Siega- Riz A-M, Laraia B. The implications of maternal overweight and obesity on the course of pregnancy and birth outcomes. Matern Child Health J[Internet].Springer US; 2006 Sep 23 [cited 2016 Dec 21]; 10(S1) : 153-6.Available from;//link.springer.com/10.1007/s10995-006-0115-x.
  2. Pednekar MS, Hakama M, Hebert JR, Gupta PC. Association of body mass indexwithall-causeand cause-specificmortality: findings from a prospective cohortstudy in Mumbai (Bombay), India. Int JEpidemiol [Internet].2008Jun 1[cited 2016 Dec 21]; 37(3):524-35.
  3. James WPT. WHO recognition of the global obesity epidemic. Int J Obes [Internet].2008 Dec [cited 2016 Dec 21]; 32:S120-6. Available from:http://www.ncbi.nlm.nih.gov/pubmed/
  4. Lakanpal S, Agarwal A. To assess the effect of maternal BMI on obstetrical outcome .International journal of advancements in research and technology 2012:1:1-9.
  5. Dasgupta A, Hari chandrakumar K T, Habeebullah S. Pregnancy outcome among obese Indians-A prospective cohort study in a tertiary care centre in south India. International journal of scientific study 2014;2:13-8.
  6. Alexandra P, Vassilios B, Alexandra V, George K, Vassiliki L, Chryssa B. Population-based trends of pregnancy outcome in obese mothers: what has changed over 15 years. Obesity. 2011 Sep;19(9):1861–5.
  7. American College of Obstetricians and Gynecologists. ACOG Committee opinion number 315, September 2005. Obesity in pregnancy. Obstetrics and Gynecology. 2005 Sep;106(3):671–5.
  8. Discussion paper: Non communicable diseases, poverty and the development agenda (July 2009) ECOSOC high level segment;2009. http://www.who.int/nmh/publications/discussion_paper_ncd_en.pdf
  9. Keys A, Fidamza F, Karvonen MJ, Kimura N, Taylor HL. Indices of relative weight and obesity. J chronic Dis[Internet]. 1972 Jul 1[cited 2016 Dec 25]; 25(6):329-43
  10. Chu SY, Kim SY, Schmidt CH, Dietz PM, et al. Maternal obesity and risk of caesarean delivery, meta analysis. Obesity Reviews 2007;8(5):9.
Recommended Articles
Research Article Open Access
Comparison of the Efficacy and Safety of Intrathecal Levobupivacaine with Clonidine Versus Hyperbaric Bupivacaine with Clonidine for Spinal Anaesthesia in Patients Undergoing Elective Lower Segment Caesarean Section (LSCS).
2026, Volume-7, Issue 4 : 1316-1324
Research Article Open Access
Study of Microbiological Spectrum and Renal Outcomes in Patients of Acute Febrile Illness with Thrombocytopenia: An Observational and Retrospective Study
2026, Volume-7, Issue 4 : 1288-1294
Research Article Open Access
A Comparative Study of Open Lichtenstein Repair and Laparoscopic Mesh Repair in Inguinal Hernia
2026, Volume-7, Issue 4 : 1331-1336
Research Article Open Access
Effectiveness Of Glycopyrronium Plus Indacaterol Combination in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease
2026, Volume-7, Issue 4 : 1273-1277
International Journal of Medical and Pharmaceutical Research journal thumbnail
Volume-7, Issue 4
Citations
3 Views
1 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
Creative Commons Attribution License Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
facebook twitter linkedin mendeley research-gate
© Copyright | International Journal of Medical and Pharmaceutical Research | All Rights Reserved